Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Glycopyrronium (25mcg) + Formoterol (12mcg)+ Budesonide (400 mcg) Rota Capsule
Therapeutic Category
Pulmonary, Respiratory, Asthma
Dosage Form
Rota cap
Packaging Type
in a bottle, silica gel,with carton
Packaging
30 Capsules
Price
₹549/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Buditerm GF is a powerful inhalation therapy designed for the effective management of chronic obstructive pulmonary disease (COPD) and asthma. Each Rota Cap contains a carefully balanced combination of Glycopyrronium (25 mcg), Formoterol (12 mcg), and Budesonide (400 mcg). This unique formulation targets multiple pathways to provide comprehensive relief from respiratory symptoms, improving overall lung function and quality of life.
Glycopyrronium is an anticholinergic agent that helps to relax the muscles around the airways, leading to bronchodilation and improved airflow. Formoterol, a long-acting beta-agonist (LABA), complements this effect by stimulating beta-2 adrenergic receptors, further enhancing bronchodilation and providing prolonged relief from wheezing and shortness of breath. Budesonide, an inhaled corticosteroid (ICS), works to reduce inflammation in the airways, addressing the underlying causes of asthma and COPD. Together, these three components create a synergistic effect that not only alleviates symptoms but also helps to prevent exacerbations.
Common side effects may include throat irritation, hoarseness, headache, and increased risk of respiratory infections. Some patients may also experience palpitations or muscle cramps. It is important to monitor for any unusual symptoms during treatment.
Glycopryl FB is indicated for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD) in adults.
Glycopryl FB should be used only as directed by a healthcare professional. Do not exceed the recommended dosage, and consult a doctor if symptoms do not improve or worsen.
Store Glycopryl FB in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children to ensure safety.
Composition : Glycopyrrolate (25mcg) Respule
Composition : Budesonide (0.5mg) Respule
Composition : Budesonide (200mcg) + Formoterol (6mcg) Rota Capsule
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
Composition : Formoterol 6mcg + Budesonide 400mcg Rota Capsule
Composition : Formoterol (6mcg) + Budesonide (400mcg) Inhaler
Composition : Formoterol (20mcg) + Budesonide (0.5mg) Respule
Composition : Levosalbutamol (1.25mg) + Budesonide (0.5mg) Respule
Composition : Levosalbutamol 100mcg + Ipratropium 40mcg
Composition : Fluticasone Propionate 250mcg + Formoterol Fumarate 6mcg Life Cap
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This triple combination has strong demand in the advanced respiratory and pulmonary care segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners focusing on COPD, severe asthma, and chronic airway disease portfolios.
Medical distributors and agencies can benefit from consistent demand for maintenance and control therapy in moderate to severe respiratory conditions. Glycopyrronium (25 mcg) is a long-acting muscarinic antagonist (LAMA) that relaxes airway muscles Formoterol (12 mcg) is a long-acting beta-agonist (LABA) that improves airflow and reduces bronchospasm Budesonide is an inhaled corticosteroid (ICS) that reduces airway inflammation This LAMA + LABA + ICS combination supports comprehensive long-term respiratory management.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Glycopyrronium + Formoterol + Budesonide Rota Cap with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong pulmonologist prescriptions, hospital and clinic demand, chronic COPD patient usage, long-term recurring sales, reliable supply chain support, and strong margins in respiratory specialty medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.